FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to an agent for treating arthritic diseases. Agent for treating arthritic diseases comprising 50 mg to 2500 mg of chondroitin sodium sulphate and at least one excipient or carrier, and also contains metallic or colloidal silver in relative amount from 0.2 mg/kg to 8 mg/kg in terms of weight of chondroitin sodium sulphate.
EFFECT: agent described above improves stability of the agent for a long period of time regardless of the form of the preparation containing said agent.
28 cl, 6 ex, 1 tbl, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739184C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
| PHARMACEUTICAL AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2023 |
|
RU2813891C1 |
| COMBINED AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2024 |
|
RU2827069C1 |
| AGENT FOR TREATING ARTHROLOGICAL DISEASES IN LYOPHILIZED FORM FOR INJECTIONS | 2024 |
|
RU2827073C1 |
| AGENT FOR TREATMENT OF JOINT DISEASE | 2005 |
|
RU2282437C1 |
| REMEDY FOR TREATING DISEASES OF JOINTS | 2005 |
|
RU2275190C1 |
| LYOPHILISED PHARMACEUTICAL COMPOSITION FOR PREPARING SOLUTION FOR INJECTIONS FOR TREATING DEGENERATE-DYSTROPHIC LOCOMOTOR DISEASES AND METHOD FOR PREPARING IT | 2011 |
|
RU2458693C1 |
| METHOD FOR PREVENTING AND TREATING ARTHROPATHIES AND METHODS FOR USING SAME | 2013 |
|
RU2521973C1 |
| AGENT FOR TREATMENT OF JOINT DISEASES | 2005 |
|
RU2275199C1 |
